IFN-γ promotes the expression of the immunosuppressive metabolite indoleamine2,3-dioxygenase (IDO) in tumor cells and host bone marrow cells by driving the upregulation of PD-L1 in these cells, thus suppressing tumor-specific T cells and contributing to the development of an immunosuppressive TME (13). Here, IDO1 is linked to neoplasm.